Literature DB >> 1696796

A bovine monoclonal antibody detecting a class I BoLA antigen.

S J Kemp1, E M Tucker, A J Teale.   

Abstract

The bovine IgG1 monoclonal antibody (mAb) ILA70 was made by immunizing a calf with peripheral blood mononuclear cells (PBM) from a BoLA-w10 homozygous heifer and subsequently fusing lymphocytes from the local lymph-node with the heterohybridoma 53B3. Family and population studies, antibody binding inhibition and immunoprecipitation of the target antigen all indicate that ILA70 detects a polymorphic epitope on a bovine class I major histocompatibility complex (MHC) molecule. The antibody is complement fixing and so may be used in a standard cytotoxicity assay. Ascitic fluid with antibody activity many times greater than that of the tissue-culture supernatant has been prepared in nude mice. The antibody-producing heterohybridoma has been subcloned three times and appears to be stable. Such heterohybridomas may prove to be a valuable source of particularly discriminating and informative mAbs for the serological analysis of the products of the bovine MHC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696796     DOI: 10.1111/j.1365-2052.1990.tb03220.x

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  3 in total

1.  Transmembrane and cytoplasmic domain sequences demonstrate at least two expressed bovine MHC class I loci.

Authors:  S A Ellis; K A Braem; W I Morrison
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Identification of expressed bovine class I MHC genes at two loci and demonstration of physical linkage.

Authors:  A Bensaid; A Kaushal; C L Baldwin; H Clevers; J R Young; S J Kemp; N D MacHugh; P G Toye; A J Teale
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 3.  Molecular Dissection of the Antibody Response: Opportunities and Needs for Application in Cattle.

Authors:  Ruben Barroso; W Ivan Morrison; Liam J Morrison
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.